A Screening Model for Probiotics Against Specific Metabolic Diseases Based on Caco-2 Monolayer Membrane

Abstract

Recent studies have revealed the potency of probiotics in alleviating metabolic diseases associated with intestinal barrier dysfunction. However, an efficient model for screening probiotic strains against specific metabolic diseases has not been well developed. In the present study, a Caco-2 cell monolayer membrane model treated with tumor necrosis factor (TNF-α) or alcohol was used to evaluate the effect of 139 Lactobacillus strains on intestinal barrier function in vitro . We then selected 11 Lactobacillus strains with different regulatory abilities on the gut barrier to determine their effect against ovariectomy-induced osteoporosis or chronic alcoholic liver injury in vivo . Our results showed that the Pearson coefficient between the data of cell and animal models were 0.82 and −0.97 for the protection of probiotics against osteoporosis and alcoholic liver disease, respectively, suggesting the reliability of the cell model to simulate the in vivo protective effects of probiotics. This study established a potential in vitro approach based on a Caco-2 cell monolayer membrane model for the efficient screening of potential probiotics against specific metabolic diseases such as osteoporosis and chronic alcoholic liver disease.